白细胞介素-10启动子基因多态性与缺血性卒中相关性的Meta分析

doi:10.3969/j.issn.1673-5765.2020.09.010

摘要/Abstract

摘要：

目的系统评价IL-10启动子基因（IL-10-1082A/G、IL-10-819T/C ）多态性与缺血性卒中（i s chemi c stroke，IS）发病风险的相关性。方法计算机检索Pubmed、Embase、Web of Science、万方数据库及中国知网数据库发表的有关IL-10启动子基因多态性与IS发病风险相关性的研究，检索时限为从建库至2019年2月，由2名评价者按照纳入与排除标准选择研究、提取资料。采用RevMan 5.3软件进行荟萃分析。结果共纳入13篇病例对照研究，其中12篇文献研究了IL-10-1082A/G 基因多态性与I S的易感性，6 篇文献研究了IL-10-819T/C 基因多态性与I S的易感性。结果显示，在总体人群中，IL-10-1082A/G基因多态性与I S发病风险之间存在相关性（G vs A：OR 0.71，95%CI 0.59～0.86，P＜0.001；GG vs AA：OR 0.61， 95%CI 0.49～0.76，P＜0.001；AG vs AA：OR 0.72，95%CI 0.55～0.94，P =0.020；GG+AG vs AA：OR 0.68， 95%CI 0.53～0.87，P =0.002；GG vs AG+AA：OR 0.68，95%CI 0.52～0.89，P =0.005）；而IL-10-819T/C 基因多态性与IS发病风险无明显相关性（P＞0.05）。对中国人群进行亚组分析后，Meta分析结果与总体人群一致。结论 IL-10-1082A/G基因的多态性与IS风险显著相关，该基因是卒中易感基因；而IL-10-819T/C基因多态性与IS的发病风险无明显关联。

文章导读： 本文明确了IL-10启动子基因多态性与卒中发病的相关性，对卒中高危人群筛查提供了依据。

关键词: 白细胞介素-10; 缺血性卒中; 基因多态性; 荟萃分析

Abstract:

Objective To systematically review the association between IL-10 promoter gene (IL-10-1082A/G , IL-10-819T/C ) polymorphism and the risk of ischemic stroke (IS) by meta analysis. Methods Databases of PubMed, Embase, Web of Science, WanFang Data and CNKI were electronically searched for the literature published up to February 2019 on the association between IL-10 promoter gene polymorphism and IS risk. According to the inclusion and exclusion criteria,the studies were screened and the data were extracted by 2 reviewers. The data were analyzed using the RevMan 5.3 software. Results A total of 13 case-control studies were included, including 12 articles on the correlation between IL-10-1082A/G gene polymorphism and IS, and 6 articles on the correlation between IL- 10-819T/C gene polymorphism and IS. The meta analysis results showed a significant association between IL-10-1082A/G gene polymorphism and IS risk in the total included patients, (G vs A: OR 0.71, 95%CI 0.59-0.86, P <0.001; GG vs AA: OR 0.61, 95%CI 0.49-0.76, P <0.001; AG vs AA: OR 0.72, 95%CI 0.55-0.94, P =0.020; GG+AG vs AA: OR 0.68, 95%CI 0.53-0.87, P =0.002; GG vs AG+AA: OR 0.68, 95%CI 0.52-0.89, P =0.005); while there was no obvious correlation between IL-10-819T/C gene polymorphism and IS risk (P >0.05). The results of subgroup analysis in the Chinese population were consistent with the overall analysis results. Conclusions IL-10-1082G/A gene polymorphism was associated with IS risk, which is stroke susceptibility gene; IL-10-819T/C gene polymorphism was not associated with IS risk.

Key words: Interleukin-10; Ischemic stroke; Polymorphism; Meta analysis

黄晶，吕学锋，张晋欣，张春艳. 白细胞介素-10启动子基因多态性与缺血性卒中相关性的Meta分析[J]. 中国卒中杂志, 2020, 15(09): 978-987.

HUANG Jing, LYU Xue-Feng, ZHANG Jin-Xin, ZHANG Chun-Ya. Association of Interleukin-10 Promoter Gene Polymorphism with Ischemic Stroke: a Meta Analysis[J]. Chinese Journal of Stroke, 2020, 15(09): 978-987.

参考文献

[1] DONNAN G A，FISHER M，MACLEOD M，et al.

Stroke[J]. Lancet，2008，371（9624）：1612-1623.

[2] DELLA-MORTE D，GUADAGNI F，PALMIROTTA

R，et al. Genetics of ischemic stroke，stroke-related

risk factors，stroke precursors and treatments[J].

Pharmacogenomics，2012，13（5）：595-613.

[3] GEORGE J，SCHWARTZENBERG S，

MEDVEDOVSKY D，et al. Regulatory T cells and

IL-10 levels are reduced in patients with vulnerable

coronary plaques[J]. Atherosclerosis，2012，222（2）：

519-523.

[4] NIU Y M，DU X Y，CAI H X，et al. Increased risks

between Interleukin-10 gene polymorphisms and

haplotype and head and neck cancer：a meta-analysis[J/

OL]. Sci Rep，2015，27（5）：17149[2019-03-21].

https：//doi.org/10.1038/srep17149.

[5] KINGO K，RÄTSEP R，KÕKS S，et al. Influence

of genetic polymorphisms on interleukin-10 mRNA

expression and psoriasis susceptibility[J]. J Dermatol

Sci，2005，37（2）：111-113.

[6] MAROUSI S，ELLUL J，ANTONACOPOULOU A，

et al. Functional polymorphisms of interleukin 4 and

interleukin 10 may predict evolution and functional

outcome of an ischaemic stroke[J]. Eur J Neurol，2011，

18（4）：637-643.

[7] TUTTOLOMONDO A，DI RAIMONDO D，FORTE

G I，et al. Single nucleotide polymorphisms（SNPs）of

pro-inflammatory/anti-inflammatory and thrombotic/

fibrinolytic genes in patients with acute ischemic

stroke in relation to TOAST subtype[J]. Cytokine，

2012，58（3）：398-405.

[8] OZKAN A，SILAN F，ULUDA? A，et al. Tumour

necrosis factor alpha，interleukin 10 and interleukin

6 gene polymorphisms of ischemic stroke patients in

south Marmara region of Turkey[J]. Int J Clin Exp

Pathol，2015，8（10）：13500-13504.

[9] MUNSHI A，RAJESHWAR K，KAUL S，et al.

Interleukin-10-1082 promoter polymorphism and

ischemic stroke risk in a South Indian population[J].

Cytokine，2010，52（3）：221-224.

[10] KUMAR P，KUMAR A，SAGAR R，et al.

Association between interleukin-10-1082G/A gene

polymorphism and risk of stroke in the North

Indian population：a case-control study[J]. J Stroke

Cerebrovasc Dis，2016，25（2）：461-468.

[11] HE W，SONG H Y，DING L H，et al. Association

between IL-10 gene polymorphisms and the risk of

ischemic stroke in a Chinese population[J]. Int J Clin

Exp Pathol，2015，8（10）：13489-13494.

[12] JIANG X H，LIN K X，ZHANG Y X，et

al. Correlating interleukin-10 promoter gene

polymorphisms with human cerebral infarction

onset[J]. Neural Regen Res，2015，10（11）：1809-1813.

[13] LI W Z，GAO C Y，HE W L，et al. Association of the

interleukin-10 gene -1082A/G genetic polymorphism

with risk of ischemic stroke in a Chinese population[J].

Genet Mol Res，2016，15（1）：1-7.

[14] TONG Y Q，CAI L，ZHANG Y W，et al. Role of

functional polymorphisms of the IL-10 gene promoter

in the risk of ischemic stroke in Chinese Uyghur

population：one case-control study[J/OL]. Int J Cardiol，

2016，211：58-60[2019-03-21]. https：//doi.org/10.1016/

j.ijcard.2016.02.151.

[15] LIU X，LI Q，ZHU R X，et al. Association of IL-

10-1082A/G polymorphism with ischemic stroke：

evidence from a case-control study to an updated

meta-analysis[J]. Genet Test Mol Biomarkers，2017，

21（6）：341-350.

[16] 张国忠，潘速跃，杜冉，等. 白细胞介素10基因多态

性与脑梗死的关系[J]. 中国脑血管病杂志，2007，4

（7）：294-297.

[17] 金磊，倪培华，吴洁敏，等. 白细胞介素10-819C/T、-

1082G/A基因多态性与脑梗死的关系[J]. 检验医学，

2011，26（11）：717-721.

[18] 袁磊，杜敢琴. IL-10启动子基因多态性与脑梗死相

关性分析[J]. 河南科技大学学报（医学版），2018，36

（4）：268-271.

[19] 胥雪莲. 炎症与动脉粥样硬化[J]. 心血管病学进展，

2015，36（5）：634-637.

[20] DE VRIES J E. Immunosuppressive and antiinflammatory

properties of Interleukin 10[J]. Ann

Med，1995，27（5）：537-541.

[21] D’ANDREA A，ASTE-AMEZAGA M，

VALIANTE N M，et al. Interleukin 10（IL-10）

inhibits human lymphocyte interferon gammaproduction

by suppressing natural killer cell

stimulatory factor/IL-12 synthesis in accessory

cells[J]. J Exp Med，1993，178（3）：1041-1048.

[22] HAN X B，BOISVERT W A. Interleukin-10 protects

against atherosclerosis by modulating multiple

atherogenic macrophage function[J]. Thromb

Haemost，2015，113（3）：505-512.

[23] DIAO Z Y，WANG C L，QI H S，et al. Significance

of decreased serum interleukin-10 levels in the

progression of cerebral infarction[J]. Clin Exp Med，

2016，16（2）：203-211.

[24] KOSS K，FANNING G C，WELSH K I，et al.

Interleukin-10 gene promoter polymorphism in

English and Polish healthy controls. Polymerase

chain reaction haplotyping using 3’ mismatches in

forward and reverse primers[J]. Genes Immun，2000，

1（5）：321-324.

[25] JIN J，LI W Y，PENG L M，et al. Relationship

between Interleukin-10 -1082A/G polymorphism and

risk of ischemic stroke：a meta-analysis[J/OL]. PloS

One，2014，9（4）：e94631[2019-03-21]. https：//doi.

org/10.1371/journal.pone.0094631.

[26] YIN G T，MA Y T，ZHENG Y Y，et al.

Polymorphisms of interleukin-10 genes on the risk of

ischemic stroke in a meta-analysis[J]. Int J Clin Exp

Med，2015，8（2）：1888-1895.